Skip to main navigation Skip to search Skip to main content

A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)

  • Siddique, Shamyla (Co-Investigator)
  • Jackson, Aimee (Co-Investigator)
  • Craddock, Charles (Principal Investigator)

Project Details

Short titleA Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
StatusFinished
Effective start/end date6/07/17 → 31/12/25

Funding

  • PFIZER LIMITED